Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
457.35
+0.32 (0.07%)
Oct 16, 2026, 3:25 PM EST
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $367.67 billion as of October 16, 2026. Its market cap has increased by 28.87% in one year.
Market Cap
367.67B
Enterprise Value
401.17B
Revenue
77.92B
Global Rank
n/a
Country Rank
n/a
PE Ratio
24.06
ChartMarket Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 367.67B, an increase of 4,097.79%. That is a compound annual growth rate of 11.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 367.42B | 10.83% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 808.86M |
| Silence Therapeutics | 562.96M |
| Nika Pharmaceuticals | 432.42M |
| American Oncology Network | 372.75M |
| CytoDyn | 321.82M |
| Northwest Biotherapeutics | 266.63M |
| Elite Pharmaceuticals | 266.05M |
| Glorywin Entertainment Group | 234.77M |